CorVel Corporation (CRVL) Q2 FY23 Earnings Call

Strong growth and capital returns face healthcare inflation and commercial pricing pressure.

Q2 FY23 results, source: company transcript and SEC filings
QuarterQ2 FY23
Length14 minutes
EPS$0.83

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q3 FY26 · Q2 FY26 · Q1 FY23

All CRVL earnings · Back to CRVL overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.